Alan King

1.5k total citations
18 papers, 1.1k citations indexed

About

Alan King is a scholar working on Biotechnology, Immunology and Infectious Diseases. According to data from OpenAlex, Alan King has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biotechnology, 8 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Alan King's work include Microbial Inactivation Methods (9 papers), Transgenic Plants and Applications (8 papers) and Viral Infections and Vectors (6 papers). Alan King is often cited by papers focused on Microbial Inactivation Methods (9 papers), Transgenic Plants and Applications (8 papers) and Viral Infections and Vectors (6 papers). Alan King collaborates with scholars based in United States, Sweden and Thailand. Alan King's co-authors include Bruce L. Innis, Jay W. Hooper, Joseph W. Golden, Anna‐Karin Roos, Pavel Pisa, Wellington Sun, Joseph J. Drabick, Stella Somiari, Robert W. Malone and Jill Glasspool‐Malone and has published in prestigious journals such as The Journal of Immunology, Journal of General Virology and Vaccine.

In The Last Decade

Alan King

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan King United States	14	484	467	279	276	235	18	1.1k
David Hallengärd Sweden	16	373 0.8×	434 0.9×	200 0.7×	100 0.4×	187 0.8×	27	772
Hansi Dean United States	18	202 0.4×	317 0.7×	256 0.9×	39 0.1×	179 0.8×	46	942
Anjali Yadava United States	19	731 1.5×	150 0.3×	538 1.9×	42 0.2×	416 1.8×	27	1.3k
Brian Keegan United States	19	490 1.0×	184 0.4×	213 0.8×	32 0.1×	226 1.0×	34	1.0k
Alexandra C. I. Depelsenaire Australia	12	323 0.7×	299 0.6×	150 0.5×	33 0.1×	91 0.4×	14	657
Jose M. Galarza United States	12	160 0.3×	408 0.9×	193 0.7×	100 0.4×	296 1.3×	18	971
Peifang Sun United States	18	906 1.9×	707 1.5×	309 1.1×	31 0.1×	215 0.9×	42	1.3k
Ken Draper United States	17	606 1.3×	560 1.2×	170 0.6×	22 0.1×	134 0.6×	23	1.3k
Ingo Jordan Germany	24	217 0.4×	709 1.5×	150 0.5×	41 0.1×	674 2.9×	59	1.6k
Jason B. Alarcon United States	8	79 0.2×	90 0.2×	273 1.0×	93 0.3×	170 0.7×	9	822

Countries citing papers authored by Alan King

Since Specialization

Citations

This map shows the geographic impact of Alan King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan King more than expected).

Fields of papers citing papers by Alan King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan King. The network helps show where Alan King may publish in the future.

Co-authorship network of co-authors of Alan King

This figure shows the co-authorship network connecting the top 25 collaborators of Alan King. A scholar is included among the top collaborators of Alan King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan King. Alan King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kulkarni, Viraj, Margherita Rosati, Rashmi Jalah, et al.. (2014). DNA vaccination by intradermal electroporation induces long‐lasting immune responses in rhesus macaques. Journal of Medical Primatology. 43(5). 329–340. 11 indexed citations

Hallengärd, David, Andreas Bråve, Maria Isaguliants, et al.. (2012). A combination of intradermal jet-injection and electroporation overcomes in vivodose restriction of DNA vaccines. PubMed. 10(1). 5–5. 22 indexed citations

Daftarian, Pirouz, Changli Wei, Alan King, et al.. (2011). In vivo Electroporation and Non-protein Based Screening Assays to Identify Antibodies Against Native Protein Conformations. Hybridoma. 30(5). 409–418. 6 indexed citations

El‐Kamary, Samer S., Stephen B. Deitz, Howard L. Rhinehart, et al.. (2011). Safety and Tolerability of the Easy Vax™ Clinical Epidermal Electroporation System in Healthy Adults. Molecular Therapy. 20(1). 214–220. 29 indexed citations

Bråve, Andreas, Lindvi Gudmundsdotter, Eric Sandström, et al.. (2010). Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine. 28(51). 8203–8209. 38 indexed citations

Roos, Anna‐Karin, et al.. (2009). Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients. Molecular Therapy. 17(9). 1637–1642. 60 indexed citations

Roos, Anna‐Karin, Alan King, & Pavel Pisa. (2008). DNA Vaccination for Prostate Cancer. Methods in molecular biology. 423. 463–472. 10 indexed citations

Biragyn, Arya, Roberta Schiavo, Purevdorj B. Olkhanud, et al.. (2007). Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8+ T Cell-Mediated Protective and Therapeutic Antitumor Immunity. The Journal of Immunology. 179(2). 1381–1388. 25 indexed citations

Hooper, Jay W., et al.. (2006). Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine. 25(10). 1814–1823. 133 indexed citations

10.

Saito, Koichiro, Mohamed Lehar, Zhao Bo Li, et al.. (2006). High efficiency gene delivery into laryngeal muscle with bidirectional electroporation. Otolaryngology. 135(2). 209–214. 7 indexed citations

11.

Roos, Anna‐Karin, Sonia Carreño-Moreno, Christoph Leder, et al.. (2005). Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Molecular Therapy. 13(2). 320–327. 102 indexed citations

12.

Sun, Wellington, Robert Edelman, Niranjan Kanesa-thasan, et al.. (2003). VACCINATION OF HUMAN VOLUNTEERS WITH MONOVALENT AND TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE CANDIDATES. American Journal of Tropical Medicine and Hygiene. 69(6_suppl). 24–31. 122 indexed citations

13.

Gwinn, William M., et al.. (2003). SEROTYPE-SPECIFIC TH1 RESPONSES IN RECIPIENTS OF TWO DOSES OF CANDIDATE LIVE-ATTENUATED DENGUE VIRUS VACCINES. American Journal of Tropical Medicine and Hygiene. 69(6_suppl). 39–47. 21 indexed citations

14.

Drabick, Joseph J., Jill Glasspool‐Malone, Stella Somiari, Alan King, & Robert W. Malone. (2001). Cutaneous Transfection and Immune Responses to Intradermal Nucleic Acid Vaccination Are Significantly Enhanced by in Vivo Electropermeabilization. Molecular Therapy. 3(2). 249–255. 118 indexed citations

15.

Kanesa-thasan, Niranjan, Wellington Sun, Stephen Van Albert, et al.. (2001). Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine. 19(23-24). 3179–3188. 179 indexed citations

16.

Kelly, Eileen P., James J. Greene, Alan King, & Bruce L. Innis. (2000). Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine. 18(23). 2549–2559. 66 indexed citations

17.

King, Alan, Ananda Nisalak, Khin Saw Aye Myint, et al.. (1999). B cells are the principal circulating mononuclear cells infected by dengue virus.. PubMed. 30(4). 718–28. 71 indexed citations

18.

Anderson, Robert, Alan King, & Bruce L. Innis. (1992). Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. Journal of General Virology. 73(8). 2155–2159. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact